Stock GKOS GLAUKOS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Glaukos Corporation

Equities

GKOS

US3773221029

Market Closed - Nyse
Other stock markets
 04:00:01 2024-05-28 pm EDT 		5-day change 1st Jan Change
109.3 USD +0.38% Intraday chart for Glaukos Corporation +0.71% +37.50%
May. 14 Glaukos Insider Sold Shares Worth $264,791, According to a Recent SEC Filing MT
May. 06 Jefferies Upgrades Glaukos to Buy From Hold, Raises Price Target to $125 From $84 MT

Evolution of the average Target Price on Glaukos Corporation

Price target over the last 5 years

History of analyst recommendation changes

8a72ceeab7c.SqJyrrWHX1qgGXnwDbq3jqjdazWV9ijZOUUMGP7Z8QE.ONo17d_pGRL_IR6-UvvN3drrBlLUz3nvayJ7SayWs24w9jPZ59A2K9RqLA~4842a46fd6247497566ba3f0d9b8d9a2

Analyst Recommendations on Glaukos Corporation

Glaukos Insider Sold Shares Worth $264,791, According to a Recent SEC Filing MT
Jefferies Upgrades Glaukos to Buy From Hold, Raises Price Target to $125 From $84 MT
Needham Adjusts Price Target on Glaukos to $113 From $108, Maintains Buy Rating MT
JPMorgan Adjusts Price Target on Glaukos to $110 From $108, Maintains Overweight Rating MT
Truist Raises Glaukos' PT to $125 From $120 After 'Solid' Q1 Beat, Keeps Buy Rating MT
Mizuho Securities Adjusts Price Target on Glaukos to $100 From $85, Maintains Neutral Rating MT
Glaukos Insider Sold Shares Worth $6,008,359, According to a Recent SEC Filing MT
Wells Fargo Hikes Price Target on Glaukos to $103 From $83, Maintains Overweight Rating MT
Needham Raises Price Target on Glaukos to $108 From $105, Maintains Buy Rating MT
Piper Sandler Raises Price Target on Glaukos to $105 From $90, Maintains Overweight Rating MT
JPMorgan Upgrades Glaukos to Overweight From Neutral, Raises Price Target to $91 From $66 MT
Morgan Stanley Initiates Glaukos With Equalweight Rating, Price Target is $65 MT
Truist Initiates Glaukos With Buy Rating, $88 Price Target MT
Wells Fargo Upgrades Glaukos to Overweight From Equalweight, Raises Price Target to $83 From $75 MT
Needham Adjusts Price Target on Glaukos to $83 From $89, Keeps Buy Rating MT
Stephens Adjusts Glaukos Price Target to $93 From $90, Maintains Overweight Rating MT
Mizuho Adjusts Price Target on Glaukos to $85 From $80, Maintains Neutral Rating MT
Piper Sandler Adjusts Glaukos' Price Target to $85 From $80, Keeps Overweight Rating MT
Needham Adjusts Price Target on Glaukos to $89 From $67, Maintains Buy Rating MT
Wells Fargo Adjusts Glaukos Price Target to $75 From $63, Maintains Equal Weight Rating MT
Citigroup Raises Price Target on Glaukos to $85 From $59, Maintains Buy Rating MT
Stifel Adjusts Price Target on Glaukos to $77 From $65, Maintains Buy Rating MT
Piper Sandler Upgrades Glaukos to Overweight From Neutral, Adjusts Price Target to $80 From $55 MT
Wells Fargo Increases Price Target on Glaukos to $63 From $44, Maintains Equalweight Rating MT
BTIG Research Adjusts Glaukos Price Target to $67 From $58, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
109.3 USD
Average target price
113.3 USD
Spread / Average Target
+3.69%
High Price Target
130 USD
Spread / Highest target
+18.94%
Low Price Target
100 USD
Spread / Lowest Target
-8.51%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Glaukos Corporation

Jefferies & Co.
Needham & Co.
JPMorgan Chase
Truist Securities
Mizuho Securities
Wells Fargo Securities
Piper Sandler
Morgan Stanley
Stephens Inc.
Citigroup
Stifel Nicolaus
BTIG
William Blair & Co.
Berenberg Bank
Oppenheimer
J.P. Morgan Chase

Ratings for Glaukos Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. GKOS Stock
  4. Consensus Glaukos Corporation